ConductScience.org, home

Paper7657

Serotoninergic modulation of the dopamine response from the nucleus accumbens.

Costall B and 3 others. J Pharm Pharmacol, 1976. Cited by 121 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serotoninergic modulation of the dopamine response from the nucleus accumbens. Papers, record 7657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7657

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serotoninergic modulation of the dopamine response from the nucleus accumbens.
PubMed
Journal
J Pharm Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
5.8
iCite
Revised in PubMed
2019-07-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Costall BB
2Naylor RJR J
3Marsden CDC D
4Pycock CJC J

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DopamineMajor topic
Medulla OblongataMajor topic
SerotoninMajor topic
Animals
Injections
Male
Mesencephalon
Motor Activity
Neural Pathways
Nialamide
Rats
Stereotaxic Techniques
Stimulation, Chemical
Time Factors

Source PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
40,590,3774-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.Addict Biol2025https://conductscience.org/library/papers/40590377PubMed
36,627,756Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.CNS Neurosci Ther2023https://conductscience.org/library/papers/36627756PubMed
33,929,084The 5-HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment-seeking individuals.Pharmacol Res Perspect2021https://conductscience.org/library/papers/33929084PubMed
15,545,015Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.Neurotox Res2004https://conductscience.org/library/papers/15545015PubMed
11,090,100Involvement of 5-HT(3) receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat.Br J Pharmacol2000https://conductscience.org/library/papers/11090100PubMed
7,870,907Effects of serotonergic manipulations on cocaine self-administration in rats.Psychopharmacology (Berl)1993https://conductscience.org/library/papers/7870907PubMed
7,130,970The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.J Neural Transm1982https://conductscience.org/library/papers/7130970PubMed
6,619,829The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.J Neural Transm1983https://conductscience.org/library/papers/6619829PubMed
6,337,612Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6337612PubMed
6,144,126Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6144126PubMed
6,109,349Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6109349PubMed
3,664,076Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats.Br J Pharmacol1987https://conductscience.org/library/papers/3664076PubMed
3,137,616Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/3137616PubMed
3,128,812Neurochemical and behavioural studies with RU-24969 in the rat.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/3128812PubMed
2,962,686Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.Br J Pharmacol1987https://conductscience.org/library/papers/2962686PubMed
2,957,600Relation between yawning behavior and central serotonergic neuronal system in rats.Naunyn Schmiedebergs Arch Pharmacol1987https://conductscience.org/library/papers/2957600PubMed
2,531,902Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2531902PubMed
2,018,630Effects of subchronic amphetamine or amfonelic acid on rat brain dopaminergic and serotonergic function.J Neural Transm Gen Sect1991https://conductscience.org/library/papers/2018630PubMed
1,837,997Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment.J Neural Transm Gen Sect1991https://conductscience.org/library/papers/1837997PubMed
1,826,8415-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward.J Neural Transm Gen Sect1991https://conductscience.org/library/papers/1826841PubMed

See all 26 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7657

GET https://conductscience.org/api/papers/v1/7657/cited_by?page=2